Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1Phase 2/3 1

Status

Not yet recruiting 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1CNS 1

Conditions

Rectal Neoplasms 1Neoplasms 1Mental Fatigue 1Fatigue 1Brain Neoplasms 1

Interventions

pembrolizumab 1254Specimen Handling 869Carboplatin 818Magnetic Resonance Spectroscopy 804Cyclophosphamide 795Cisplatin 716Nivolumab 648Paclitaxel 623Radiotherapy 567Gemcitabine 565Biopsy 529Bevacizumab 468Dexamethasone 434fludarabine 404Docetaxel 373venetoclax 366Oxaliplatin 362Capecitabine 353Fluorouracil 352atezolizumab 341Rituximab 327durvalumab 326Doxorubicin 313Radiosurgery 306Pemetrexed 303Drug Therapy 295Standard of Care 292Ipilimumab 290Etoposide 280Radiation 278

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Sildenafil Citrate × 1 year × Clear all
NCT06123156 2026-05-12

RECTIL

University Hospital, Rouen

Phase 3 Recruiting
188 enrolled
Gastrointestinal

Rectal Neoplasms

NCT06800092 2026-05-11

SPARC

The University of Texas Medical Branch, Galveston

Phase 2/3 Not yet recruiting
30 enrolled

Fatigue, Mental Fatigue, Neoplasms

NCT07039760 2026-03-11

Asciminib With or Without Sildenafil for Brain Tumors

Washington University School of Medicine

Phase EARLY_PHASE1 Not yet recruiting
12 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡